AMRN:NASDAQ
Amarin Corporation PLC
$13.80
arrow_downward
-1.71%(-0.24) 1D
Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$14.09
High
$14.10
Low
$13.68
Mkt. cap
291.50M
Avg. vol.
73.44K
Volume
49.37K
52-wk high
$20.90
52-wk low
$13.12
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
Open
$14.09
High
$14.10
Low
$13.68
Mkt. cap
291.50M
Avg. vol.
73.44K
Volume
49.37K
52-wk high
$20.90
52-wk low
$13.12
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com